Management Across Settings: An Ambulatory and Community Perspective for Patients Undergoing CAR T-Cell Therapy in Multiple Care Settings.

This article presents an overview of key considerations for referring providers and institutions prior to and following CAR T-cell therapy.
METHODS: Definitions of the consultation and workup, leukapheresis, bridging, lymphodepleting chemotherapy, infusion and monitoring, and long-term follow-up phases are presented, along with specific considerations for referring centers.
FINDINGS: Although CAR T-cell therapy is limited to select centers, the process of supporting and educating patients and their caregivers requires a partnership between referring and treating providers. As CAR T-cell indications expand, management of patients in diverse settings requires a collaborative and evidence-based approach to support safe and effective care.
PMID: 30880815 [PubMed - in process]

Source: Clinical Journal of Oncology Nursing - March 19, 2019 Category: Nursing Authors: Beaupierre A, Lundberg R, Marrero L, Jain M, Wang T, Alencar MC Tags: Clin J Oncol Nurs Source Type: research